391 related articles for article (PubMed ID: 11202802)
1. Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic radiosurgery plus whole-brain radiotherapy.
Nieder C; Nestle U; Walter K; Niewald M; Schnabel K
Am J Clin Oncol; 2000 Dec; 23(6):584-8. PubMed ID: 11202802
[TBL] [Abstract][Full Text] [Related]
2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
5. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
6. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS.
Dutta D; Reddy SK; Kamath RK; Sreenija Y; Nair H; Sashidharan A; Remesan Nair RA; Pushpuja KU; Kannan R; Edappattu A; Haridas NK; Jose WM; Keechilat P
Neurol India; 2023; 71(1):62-71. PubMed ID: 36861576
[TBL] [Abstract][Full Text] [Related]
8. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
Rusthoven CG; Yamamoto M; Bernhardt D; Smith DE; Gao D; Serizawa T; Yomo S; Aiyama H; Higuchi Y; Shuto T; Akabane A; Sato Y; Niranjan A; Faramand AM; Lunsford LD; McInerney J; Tuanquin LC; Zacharia BE; Chiang V; Singh C; Yu JB; Braunstein S; Mathieu D; Touchette CJ; Lee CC; Yang HC; Aizer AA; Cagney DN; Chan MD; Kondziolka D; Bernstein K; Silverman JS; Grills IS; Siddiqui ZA; Yuan JC; Sheehan JP; Cordeiro D; Nosaki K; Seto T; Deibert CP; Verma V; Day S; Halasz LM; Warnick RE; Trifiletti DM; Palmer JD; Attia A; Li B; Cifarelli CP; Brown PD; Vargo JA; Combs SE; Kessel KA; Rieken S; Patel S; Guckenberger M; Andratschke N; Kavanagh BD; Robin TP
JAMA Oncol; 2020 Jul; 6(7):1028-1037. PubMed ID: 32496550
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
11. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
13. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
Aoyama H; Shirato H; Tago M; Nakagawa K; Toyoda T; Hatano K; Kenjyo M; Oya N; Hirota S; Shioura H; Kunieda E; Inomata T; Hayakawa K; Katoh N; Kobashi G
JAMA; 2006 Jun; 295(21):2483-91. PubMed ID: 16757720
[TBL] [Abstract][Full Text] [Related]
15. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
[TBL] [Abstract][Full Text] [Related]
17. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.
Shehata MK; Young B; Reid B; Patchell RA; St Clair W; Sims J; Sanders M; Meigooni A; Mohiuddin M; Regine WF
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):87-93. PubMed ID: 15093903
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
Kondziolka D; Patel A; Lunsford LD; Kassam A; Flickinger JC
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):427-34. PubMed ID: 10487566
[TBL] [Abstract][Full Text] [Related]
19. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer.
Wegner RE; Olson AC; Kondziolka D; Niranjan A; Lundsford LD; Flickinger JC
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e21-7. PubMed ID: 21345622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]